5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Study of REGEND001 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderNot yet recruitingPhase 32026-09-24NCT07828353
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyChronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorderRecruitingEarly phase 12026-03-23NCT07355868
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, type 2 diabetes mellitus, urinary system disorderRecruitingPhase 12026-03-17NCT07275788
Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapyidiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorderNot yet recruitingEarly phase 12026-01-22NCT07359963
Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem CellsBronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchitis, lung disorder, obstructive lung disease, respiratory system disorderRecruitingEarly phase 12026-01-14NCT07239895